JP2008104623A - Container-cum-syringe - Google Patents

Container-cum-syringe Download PDF

Info

Publication number
JP2008104623A
JP2008104623A JP2006289730A JP2006289730A JP2008104623A JP 2008104623 A JP2008104623 A JP 2008104623A JP 2006289730 A JP2006289730 A JP 2006289730A JP 2006289730 A JP2006289730 A JP 2006289730A JP 2008104623 A JP2008104623 A JP 2008104623A
Authority
JP
Japan
Prior art keywords
cylinder
hole
tip
container
chamber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006289730A
Other languages
Japanese (ja)
Inventor
Seiji Shimazaki
誠二 島崎
Makoto Kakiuchi
誠 垣内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arte Corp
Original Assignee
Arte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arte Corp filed Critical Arte Corp
Priority to JP2006289730A priority Critical patent/JP2008104623A/en
Publication of JP2008104623A publication Critical patent/JP2008104623A/en
Pending legal-status Critical Current

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To make it possible to observe the state of medical liquid before injection well, and to surely prevent the medical liquid from projecting from an injection needle so as to inject the medical liquid to a human body at ease. <P>SOLUTION: The containr-cum-syringe 1 comprises: a cylinder 2 where a bypass path 2a is formed; front and rear stoppers 5a and 5b fitted to a rear chamber 2c on the rear side of the bypass path 2a for liquid-tightly sealing the medical liquid m filled in the rear chamber 2c; a cylinder tip 3 provided with a lure point 3a and fitted to the front end of the cylinder 2; a finger grip 4 fitted to the rear end of the cylinder 2; and a plunger rod 6 connected to the rear stopper 5b. The length L of the bypass path 2a is longer than the front stopper 5a, the length L2 of a front chamber 2b is set longer than the mutual distance L3 of the front and rear stoppers 5a and 5b in the rear chamber 2c, and a medical liquid guiding member 9 for mitigating the flow of the medical liquid m from the front chamber 2b to the distal end side of the lure point 3 and making it pass through is mounted inside the through-hole 3f of the lure point 3. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、シリンダの先端に嵌着された筒先のルアーの内部に薬液誘導部材を設けてなる容器兼用注射器に関するものである。   The present invention relates to a container-use syringe in which a drug solution guiding member is provided inside a lure at the end of a cylinder fitted to the tip of a cylinder.

従来、シリンダと、該シリンダ内の前後端側に嵌入され、シリンダ内に充填された薬液を液密に封止する前部ストッパーおよび後部ストッパーと、前記シリンダの先端に嵌着され、前部ストッパーが入り込むバイパスチャンバーおよびその先端の注射針を取り付けるためのルアー先が設けられた筒先と、前記シリンダの後端に嵌着されたフィンガーグリップと、前記シリンダの後端部からシリンダ内に挿入されて前記後部ストッパーに連結されたプランジャーロッドとを備え、使用時にプランジャーロッドによって後部ストッパーを押して薬液と共に前部ストッパーを前方へ押し進めると、該前部ストッパーがシリンダから押し出されて前記筒先のバイパスチャンバー内に入り込むことによって、前後部ストッパー間に密封されていた薬液が、先端側の密封を解除されてシリンダ内からバイパスチャンバー内に流出し、前部ストッパーとバイパスチャンバーとの隙間を流れ、該バイパスチャンバーの内壁に設けられたバイパス溝に沿ってルアー先の内面に誘導されて注射針へと導入されるようにした容器兼用注射器が知られている(例えば、特許文献1、特許文献2参照)。
特公昭62−58745号公報 特開平8−141081号公報
Conventionally, a cylinder, a front stopper and a rear stopper, which are fitted on the front and rear end sides of the cylinder and seal the chemical liquid filled in the cylinder, and a front stopper A cylinder chamber provided with a bypass chamber into which the needle enters and a luer tip for attaching a syringe needle at the tip thereof, a finger grip fitted to the rear end of the cylinder, and inserted into the cylinder from the rear end of the cylinder A plunger rod connected to the rear stopper, and when in use, the rear stopper is pushed by the plunger rod and the front stopper is pushed forward together with the chemical solution. By entering the inside, the liquid medicine sealed between the front and rear stoppers The seal on the tip side is released and the gas flows out from the cylinder into the bypass chamber, flows through the gap between the front stopper and the bypass chamber, and is guided to the inner surface of the lure tip along the bypass groove provided on the inner wall of the bypass chamber. A container-use syringe that is introduced into a syringe needle is known (see, for example, Patent Document 1 and Patent Document 2).
Japanese Examined Patent Publication No. 62-58745 Japanese Patent Laid-Open No. 8-148101

しかしながら、前記容器兼用注射器においては、密封を解除された薬液はシリンダ内から前記バイパスチャンバー内に流入し、先にバイパスチャンバー内に入った前部ストッパーの外周面と前記バイパス溝との間の狭い隙間を通って注射針に誘導されるため、人体に注射される薬液の注射直前の状態を気泡も含めて良く見ることができないという問題があった。   However, in the container / syringe, the unsealed drug solution flows into the bypass chamber from the cylinder, and is narrow between the outer peripheral surface of the front stopper that has previously entered the bypass chamber and the bypass groove. Since it is guided to the injection needle through the gap, there is a problem that the state immediately before the injection of the liquid medicine injected into the human body cannot be seen well including bubbles.

本発明は、上記事情に鑑みてなされたものであって、注射前の薬液の状態を良く観察することができる共に、薬液が注射針から突出するのを確実に防止することができて、安心して人体に薬液を注射することができる容器兼用注射器を提供することを目的とする。   The present invention has been made in view of the above circumstances. It is possible to observe well the state of the drug solution before injection and to reliably prevent the drug solution from protruding from the injection needle. It is an object of the present invention to provide a container-use syringe that can inject a medical solution into a human body.

本発明は、前記課題を解決するために、以下の点を特徴としている。
すなわち、請求項1に係る容器兼用注射器は、透明な材料からなり、軸方向の中間部にシリンダ壁を外側に膨出してなるバイパス路が形成されたシリンダと、前記バイパス路の後側におけるシリンダの後室内にその軸方向に間隔をあけて嵌入され、後室内に充填された薬液を相互間で液密に封止する前部ストッパーおよび後部ストッパーと、先端に注射針を取り付けるルアー先が設けられ、基端部を前記シリンダの前端外周部に嵌着された筒先と、前記シリンダの後端外周部に設けられたフィンガーグリップと、前記シリンダの後端部からシリンダ内に挿入されて前記後部ストッパーに連結されたプランジャーロッドとを備えた容器兼用注射器であって、前記シリンダのバイパス路の長さが前記前部ストッパーの軸長より長く設定されると共に、前記バイパス路の前側におけるシリンダの前室の長さが前記シリンダの後室内で薬液で隔てられている前記前部ストッパーと後部ストッパーの相互間距離より長く設定され、また、前記筒先のルアー先に形成されてシリンダに連通する通孔には、シリンダ側に位置して、シリンダ内から前記通孔に導入される薬液を通孔の軸線に交差する方向から軸線に沿う方向へ屈折させて通過させる薬液誘導路を設けた薬液誘導部材が装着されていることを特徴としている。
The present invention is characterized by the following points in order to solve the above problems.
That is, the container-use syringe according to claim 1 is made of a transparent material, and has a cylinder formed with a bypass passage formed by bulging the cylinder wall outward in an axial intermediate portion, and a cylinder on the rear side of the bypass passage. The front and rear stoppers are fitted in the rear chamber with a gap in the axial direction and the liquid medicine filled in the rear chamber is sealed in a liquid-tight manner. A cylinder tip having a base end fitted to the outer periphery of the front end of the cylinder, a finger grip provided on the outer periphery of the rear end of the cylinder, and the rear portion inserted into the cylinder from the rear end of the cylinder A container-use syringe including a plunger rod connected to a stopper, wherein the length of the bypass path of the cylinder is set to be longer than the axial length of the front stopper. The length of the front chamber of the cylinder on the front side of the bypass path is set to be longer than the distance between the front stopper and the rear stopper separated by the chemical solution in the rear chamber of the cylinder. The through hole formed in the cylinder and communicating with the cylinder is located on the cylinder side, and the chemical solution introduced into the through hole from the inside of the cylinder is refracted from the direction intersecting the axis of the hole to the direction along the axis. A chemical solution guide member provided with a chemical solution guide path is attached.

また、請求項2に係る容器兼用注射器は、請求項1に記載の容器兼用注射器において、前記筒先のシリンダが嵌入される嵌着穴の底部には、前記通孔に連通しそれより大径の凹部が形成され、前記薬液誘導部材は、前記通孔に嵌合される軸部と、該軸部のシリンダ側の基端部に設けられて前記凹部に没入され、前記通孔より大径で前記凹部の外径より小径に形成され、前記凹部との間に環状間隙を形成するフランジと、該フランジの前記凹部の底面側に通孔の半径方向に向けて設けた導入溝および前記軸部の外周に軸方向に沿って形成され、一端を前記導入溝に連絡され他端を前記軸部の先端に開口させた流通溝で構成される薬液誘導路とを備えていることを特徴としている。   Further, the container-use syringe according to claim 2 is the container-use syringe according to claim 1, wherein the bottom of the fitting hole into which the cylinder at the end of the tube is fitted is connected to the through hole and has a larger diameter. A concave portion is formed, and the chemical solution guide member is provided at a shaft portion fitted in the through hole and a base end portion on the cylinder side of the shaft portion and is immersed in the concave portion, and has a larger diameter than the through hole. A flange that is formed to have a smaller diameter than the outer diameter of the recess and that forms an annular gap with the recess, an introduction groove that is provided on the bottom surface of the recess in the radial direction of the through hole, and the shaft portion And a chemical solution guide path which is formed along the axial direction and includes a flow groove having one end connected to the introduction groove and the other end opened to the tip of the shaft portion. .

また、請求項3に係る容器兼用注射器は、請求項2に記載の容器兼用注射器において、
前記ルアー先の通孔は、前記嵌着穴側を大径としルアー先の先端側を小径としたテーパ孔に形成され、その嵌着穴側寄りの位置に周方向に沿って環状溝が設けられ、前記薬液誘導部材の軸部の外周には、前記通孔のテーパ孔に整合するテーパが設けられると共に、前記通孔の環状溝に嵌合する環状の突条が周方向に沿って設けられていることを特徴としている。
Moreover, the container combined syringe which concerns on Claim 3 is a container combined syringe of Claim 2,
The luer tip through hole is formed in a tapered hole having a large diameter on the fitting hole side and a small diameter on the tip side of the luer tip, and an annular groove is provided along the circumferential direction at a position near the fitting hole side. A taper that matches the tapered hole of the through hole is provided on the outer periphery of the shaft portion of the chemical liquid guiding member, and an annular protrusion that fits in the annular groove of the through hole is provided along the circumferential direction. It is characterized by being.

また、請求項4に係る容器兼用注射器は、請求項2または3に記載の容器兼用注射器において、前記凹部とフランジとの間の環状間隙におけるシリンダ側の端部には、薬液中の不溶物の環状間隙への侵入を阻止するフィルターが設けられていることを特徴としている。   The container-use syringe according to claim 4 is the container-use injector according to claim 2 or 3, wherein an insoluble substance in the drug solution is present at the end of the annular gap between the recess and the flange on the cylinder side. It is characterized in that a filter that prevents entry into the annular gap is provided.

また、請求項5に係る容器兼用注射器は、請求項4に記載の容器兼用注射器において、前記フランジにおけるシリンダ側の端部には、前記シリンダ内を前記環状間隙に連通させる複数の小孔を周方向に間隔をあけて配設したフランジ板が、その外周部を前記嵌着穴の底部に密着させるように設けられ、前記フィルターが前記小孔を覆うようにしてフランジ板に装着されていることを特徴としている。   Further, the container-use syringe according to claim 5 is the container-use injector according to claim 4, wherein a plurality of small holes for communicating the inside of the cylinder with the annular gap are provided at the end of the flange on the cylinder side. A flange plate arranged at intervals in the direction is provided so that its outer peripheral portion is in close contact with the bottom portion of the fitting hole, and the filter is mounted on the flange plate so as to cover the small hole. It is characterized by.

本発明によれば、以下の優れた効果を奏する。
請求項1に係る容器兼用注射器によれば、シリンダのバイパス路の位置に前部ストッパーが押し込まれることにより前側の密封を解除された薬液が、バイパス路より後方のシリンダの後室から前記バイパス路を通ってバイパス路の前側のシリンダの前室内に全量入り込むので、該シリンダの前室内において、従来の容器兼用注射器の筒先では見えにくかった注射前の薬液の状態を、気泡も含めて透明なシリンダの外側から良く観察することができ、一般の注射器と同じように前室内に残る気泡を注射針を通して完全に外部に排出してから、安心して薬液を人体に注射することができる。
また、前記のようにシリンダのバイパス路の位置に前部ストッパーが押し込まれることにより、前側の密封を解除された薬液がバイパス路を通って前室内に入り込む際、バイパス路の狭い通路を通過した薬液が前室内から一気にルアー先の通孔内に流れ込もうとするが、前記通孔内で薬液の流れを薬液誘導部材の薬液誘導路が効果的に緩和するので、注射針の先端から薬液が突出する水鉄砲現象を確実に防止することができる。
The present invention has the following excellent effects.
According to the container-combined syringe of claim 1, the chemical solution whose front seal has been released by the front stopper being pushed into the position of the bypass path of the cylinder is transferred from the rear chamber of the cylinder behind the bypass path to the bypass path. Since the entire amount enters the front chamber of the cylinder on the front side of the bypass passage, the state of the liquid medicine before injection, which is difficult to see in the cylinder tip of the conventional syringe serving as a container, in the front chamber of the cylinder, including bubbles, is a transparent cylinder. The air bubbles remaining in the front chamber can be completely discharged to the outside through the injection needle in the same manner as a general syringe, and the drug solution can be safely injected into the human body.
Further, as described above, when the front stopper is pushed into the position of the bypass path of the cylinder, when the chemical solution whose front side is released passes through the bypass path and enters the front chamber, it passes through the narrow passage of the bypass path. The chemical solution tries to flow into the through hole of the lure tip from the front chamber at once, but the chemical solution guide path of the chemical solution guide member effectively relaxes the flow of the chemical solution in the through hole, so that the chemical solution from the tip of the injection needle The water gun phenomenon that protrudes can be reliably prevented.

また、請求項2に係る容器兼用注射器によれば、導入溝と流通溝とにより屈折した薬液誘導溝を薬液誘導部材に容易に形成することができると共に、ルアー先の通孔内の薬液の流れを的確に緩和することができる。   Further, according to the syringe for both containers according to claim 2, the drug solution guiding groove refracted by the introduction groove and the flow channel can be easily formed in the drug solution guiding member, and the flow of the drug solution in the through hole of the luer tip Can be mitigated accurately.

また、請求項3に係る容器兼用注射器によれば、薬液誘導部材をルアー先の通孔に軸部を容易に挿入させて組み付けることができると共に、前記軸部の環状の突条と前記通孔の環状溝との嵌合により、前記薬液誘導部材を前記通孔内にしっかりと保持させることができる。   According to the container-use syringe according to claim 3, the medicinal solution guiding member can be assembled by inserting the shaft portion into the through-hole of the luer tip easily, and the annular protrusion of the shaft portion and the through-hole. The chemical liquid guiding member can be firmly held in the through hole by fitting with the annular groove.

また、請求項4に係る容器兼用注射器によれば、二室式容器兼用注射器において凍結乾燥製剤を溶解液に液状に溶解させて注射する場合に、万一、シリンダ内の薬液中に乾燥製剤の不溶物が発生しても、該不溶物は薬液がシリンダ内から前記ルアー先の通孔に入る際にフィルターによって濾過されるので、前記不溶物が前記通孔を通って注射針から人体に注入されるのを確実に防止することができる。   Moreover, according to the syringe for both containers according to claim 4, when the freeze-dried preparation is dissolved in the liquid solution and injected in the two-chamber container-use syringe, the dry preparation should be in the liquid medicine in the cylinder. Even if insoluble matter is generated, the insoluble matter is filtered by the filter when the chemical solution enters the through-hole of the lure tip from the inside of the cylinder, so that the insoluble matter is injected into the human body from the injection needle through the through-hole. Can be surely prevented.

また、請求項5に係る容器兼用注射器によれば、シリンダ内からルアー先の通孔内に薬液が入り込む入口部に、フランジ板によってフィルターをしっかりと安定した状態で容易に設置することができる。   In addition, according to the syringe for both containers according to the fifth aspect, the filter can be easily installed in a stable and stable state by the flange plate at the inlet portion where the chemical solution enters from the inside of the cylinder into the through-hole of the luer tip.

以下、本発明の一実施の形態に係る容器兼用注射器について、添付図面を参照して説明する。
図1において、1は本発明の一実施の形態に係る容器兼用注射器を示す。この容器兼用注射器1は、シリンダ2と、該シリンダ2の前端(図1で左端)の外周部に嵌着された筒先3と、前記シリンダ2の後端(図1右端)の外周部に嵌着された合成樹脂製のフィンガーグリップ4と、前記シリンダ2内にその軸方向に間隔をあけて嵌入されて往復動可能に設けられ、シリンダ2内に充填された薬液mを相互間で封止する前部ストッパー5aおよび後部ストッパー5bと、前記シリンダ2内にその後端から挿入されて先端部を前記後部ストッパー5bに連結され、該後部ストッパー5bをシリンダ2の軸方向に往復動させるプランジャーロッド6と、前記筒先3の先端に設けたルアー先3aに装着された注射針7と、該注射針7を覆うプロテクター8とを備えている。
Hereinafter, a container-use syringe according to an embodiment of the present invention will be described with reference to the accompanying drawings.
In FIG. 1, reference numeral 1 denotes a container-use syringe according to an embodiment of the present invention. The container-use syringe 1 is fitted to a cylinder 2, a cylinder tip 3 fitted to the outer periphery of the front end (left end in FIG. 1) of the cylinder 2, and an outer periphery of the rear end (right end of FIG. 1) of the cylinder 2. The finger grip 4 made of synthetic resin and the chemical liquid m filled in the cylinder 2 are sealed between each other, and is provided in the cylinder 2 so as to be reciprocated by being inserted into the cylinder 2 with an interval in the axial direction. Front stopper 5a and rear stopper 5b, and a plunger rod which is inserted into the cylinder 2 from the rear end thereof, the front end portion is connected to the rear stopper 5b, and the rear stopper 5b is reciprocated in the axial direction of the cylinder 2. 6, an injection needle 7 attached to a luer tip 3 a provided at the tip of the tube tip 3, and a protector 8 that covers the injection needle 7.

前記シリンダ2は、透明なガラス製円筒からなり、その軸方向の中央よりやや前方に寄った中間部におけるシリンダ壁の一部を外側に膨出して形成された1つのバイパス路2aが設けられ、該バイパス路2aの前側(図1で左側)が前室2bとされ、バイパス路2aより後側(図1で右側)が後室2cとされ、共に内径は同一となっている。前記バイパス路2aのシリンダ2の軸方向における通路2a1の長さLは、前記前部ストッパー5aの軸長(厚さ)L1より長く、例えば、前部ストッパー5aの軸長の1.3倍〜1.7倍に設定されている。   The cylinder 2 is made of a transparent glass cylinder, and is provided with one bypass passage 2a formed by bulging a part of the cylinder wall in the middle portion slightly closer to the front than the center in the axial direction. The front side (left side in FIG. 1) of the bypass path 2a is a front chamber 2b, and the rear side (right side in FIG. 1) of the bypass path 2a is a rear chamber 2c, both of which have the same inner diameter. The length L of the passage 2a1 in the axial direction of the cylinder 2 of the bypass passage 2a is longer than the axial length (thickness) L1 of the front stopper 5a, for example, 1.3 times the axial length of the front stopper 5a. It is set to 1.7 times.

そして、前記前、後部ストッパー5a,5bは、それぞれ前記シリンダ2の内径より僅かに大きな外径とされ、医療用医薬品用のゴム等の材質からなる弾力性を有する材料で形成され、前部ストッパー5aが前記後室2cにおけるバイパス路2aの後端より少し後寄りに位置し、また、後部ストッパー5bが前部ストッパー5aから後方へ離間してそれらの間でシリンダ2の後室2c内に所定容量の薬液mを丁度充填し得る位置に位置してそれぞれ前記後室2cに嵌入され、該後室2c内に充填された薬液mを密封するようになっている。
なお、前記シリンダ2の前室2bの容積は、前記後室2cにおける前、後部ストッパー5a,5b間に充填された薬液mの容積をやや超える容積とされ、それに対応して、前室2bの軸長(長さ)L2が、前記後室2c内で薬液mで隔てられている前、後部ストッパー5a,5bの相互間距離L3より長く設定されている。
The front and rear stoppers 5a and 5b each have an outer diameter slightly larger than the inner diameter of the cylinder 2, and are formed of an elastic material made of a material such as rubber for medical drugs. 5a is positioned slightly rearward from the rear end of the bypass passage 2a in the rear chamber 2c, and the rear stopper 5b is spaced rearward from the front stopper 5a so as to be within the rear chamber 2c of the cylinder 2 between them. It is positioned at a position where it can be filled with a volume of chemical solution m, and is inserted into the rear chamber 2c, and the chemical solution m filled in the rear chamber 2c is sealed.
The volume of the front chamber 2b of the cylinder 2 is slightly larger than the volume of the chemical solution m filled between the front and rear stoppers 5a and 5b in the rear chamber 2c. The axial length (length) L2 is set to be longer than the distance L3 between the rear stoppers 5a and 5b before being separated by the chemical solution m in the rear chamber 2c.

前記筒先3は、透明な合成樹脂材料で成型して構成され、前側を閉鎖された円筒状の基端部3bと、該基端部3bの前端に結合された前記ルアー先3aと、該ルアー先3aの外側に間隔をあけて前記基端部3bの前端に結合されたルアーロック部3cとを備え、前記基端部3bの内側に形成された嵌着穴3dに、その底部3eに前端が当接するまで前記シリンダ2を嵌入させることにより、前記筒先3が前記シリンダ2の前端部に液密に嵌着されている。前記ルアー先3aには、その軸線上に前後に貫通して内端側を前記嵌着穴3dの底部3eに開口して前記シリンダ2の前室2bに連絡する通孔3fが設けられている。
なお、前記ルアーロック部3cには、前記注射針7の針もとを係止するロックネジ3gと前記プロテクター8を係止する環状溝3hとが設けられている。前記筒先3はルアーロック部3cを設けない筒先として形成したものであってもよい。
The tube tip 3 is formed by molding with a transparent synthetic resin material, and has a cylindrical base end portion 3b closed at the front side, the luer tip 3a coupled to the front end of the base end portion 3b, and the lure A luer lock portion 3c that is coupled to the front end of the base end portion 3b with a space outside the tip 3a. The fitting hole 3d formed inside the base end portion 3b has a front end at the bottom 3e. By inserting the cylinder 2 until it comes into contact, the tube tip 3 is liquid-tightly fitted to the front end portion of the cylinder 2. The luer tip 3a is provided with a through hole 3f that penetrates forward and backward on its axis and opens the inner end side to the bottom 3e of the fitting hole 3d and communicates with the front chamber 2b of the cylinder 2. .
The luer lock portion 3c is provided with a lock screw 3g for locking the base of the injection needle 7 and an annular groove 3h for locking the protector 8. The tube tip 3 may be formed as a tube tip not provided with the luer lock portion 3c.

そして、前記ルアー先3aの通孔3fは、前記嵌着穴3d側が大径とされルアー先3aの先端側を小径とされた緩やかな傾斜のテーパ孔に形成されると共に、嵌着穴3d側に寄った位置に周方向に沿って横断面が円弧状の環状溝3jが設けられており、また、前記嵌着穴3dの底部3eには、前記通孔3fより大径でありシリンダ2の内径より小径の円形の凹部3kが形成されている。そして、前記通孔3fには、その中央より前記嵌着穴3d側に寄った位置に(シリンダ2側に位置して)、前記シリンダ2の前室2bからルアー先3aの先端側への薬液mの流れを緩和して通過させる薬液誘導部材9が装着されている。   The through-hole 3f of the luer tip 3a is formed as a gently inclined taper hole having a large diameter on the fitting hole 3d side and a small diameter on the tip side of the luer tip 3a, and on the fitting hole 3d side. An annular groove 3j having a circular cross section along the circumferential direction is provided at a position close to the center of the cylinder 2 and the bottom 3e of the fitting hole 3d has a diameter larger than that of the through hole 3f. A circular recess 3k having a smaller diameter than the inner diameter is formed. In the through hole 3f, a chemical solution from the front chamber 2b of the cylinder 2 to the distal end side of the luer tip 3a is located closer to the fitting hole 3d side than the center (located on the cylinder 2 side). A chemical liquid guiding member 9 that allows the flow of m to pass through is attached.

前記薬液誘導部材9は、図2〜図5に示すように、外周部に前記通孔3fのテーパ孔に整合するテーパが設けられて通孔3fに嵌合される軸部10と、該軸部10のシリンダ2側の基端部に一体に設けられ、前記通孔3fより大径で前記筒先3の凹部3kの外径より小径に形成されたフランジ11とを備えている。
前記軸部10の外周には、軸部10の軸方向に沿って形成されて先端(他端)を軸部10の先端に開口された流通溝10aが、軸部10の周方向に間隔をあけて複数個(図示の例では4個)設けられると共に、前記軸方向の中央よりやや前記フランジ11側に寄った位置に、前記通孔3fの環状溝3jに嵌合する環状の突条10bが周方向に沿って設けられている。
As shown in FIGS. 2 to 5, the chemical liquid guiding member 9 is provided with a shaft portion 10 provided with a taper that matches the tapered hole of the through hole 3 f on the outer peripheral portion and fitted into the through hole 3 f, and the shaft A flange 11 is provided integrally with the base end portion of the portion 10 on the cylinder 2 side, and has a diameter larger than the through hole 3f and smaller than the outer diameter of the recess 3k of the tube tip 3.
On the outer periphery of the shaft portion 10, a flow groove 10 a formed along the axial direction of the shaft portion 10 and having the tip (the other end) opened at the tip of the shaft portion 10 is spaced in the circumferential direction of the shaft portion 10. A plurality of (four in the illustrated example) are provided, and an annular protrusion 10b that fits in the annular groove 3j of the through hole 3f at a position slightly closer to the flange 11 side than the center in the axial direction. Are provided along the circumferential direction.

前記フランジ11は、大径の外側フランジ部11aと小径の内側フランジ部11bとからなり、前記内側フランジ部11bが前記軸部10の基端部に一体に結合されており、前記内側フランジ部11bには、前記軸部10(通孔3f)の半径方向に向けて形成され、前記流通溝10aの基端(一端)に連絡された複数個(図示の例では4個)の導入溝11cが、前記内側フランジ部11bの周方向に間隔をあけて設けられている。
そして、前記軸部10が前記筒先3の通孔3fに装着された際に、軸部10の突条10bが通孔3fの環状溝3jに嵌合され、前記フランジ11が、その内側フランジ11bの端面を前記凹部3kの底面に当接させて該凹部3kに没入され、該凹部3kの内周壁との間に環状間隙eが形成されると共に、該環状溝eが、前記凹部3kの底面側にある前記内側フランジ部11bの前記導入溝11cを通して前記軸部10の流通溝10aに連絡されている。前記流通溝10aと導入溝11cとは、薬液mを前記シリンダ2内から環状間隙eを経て、前記通孔3fの軸線に直角に交差する方向からその軸線に沿う方向へ屈折させて通過させる薬液誘導路9aを構成している。
The flange 11 includes a large-diameter outer flange portion 11a and a small-diameter inner flange portion 11b. The inner flange portion 11b is integrally coupled to a base end portion of the shaft portion 10, and the inner flange portion 11b. Are formed in the radial direction of the shaft portion 10 (through hole 3f) and have a plurality (four in the illustrated example) of introduction grooves 11c connected to the base end (one end) of the flow groove 10a. The inner flange portion 11b is provided at intervals in the circumferential direction.
And when the said shaft part 10 is mounted | worn with the through-hole 3f of the said cylinder tip 3, the protrusion 10b of the shaft part 10 is fitted by the annular groove 3j of the through-hole 3f, and the said flange 11 is the inner flange 11b. The end surface of the recess 3k is brought into contact with the bottom surface of the recess 3k to be immersed in the recess 3k, an annular gap e is formed between the inner peripheral wall of the recess 3k, and the annular groove e is formed on the bottom surface of the recess 3k. It is connected to the flow groove 10a of the shaft portion 10 through the introduction groove 11c of the inner flange portion 11b on the side. The flow groove 10a and the introduction groove 11c allow the chemical solution m to pass through the cylinder 2 through the annular gap e and be refracted from the direction perpendicular to the axis of the through hole 3f to the direction along the axis. A guiding path 9a is configured.

なお、前記シリンダ2の前端の外周部にはリング状の突起2dが設けられて、該突起2dが前記筒先3の嵌着穴3dの前端部に形成されたリング状溝3iに嵌合されることにより、筒先3がシリンダ2の前端部に気密、液密的に嵌着され、同様に、前記シリンダ2の後端の外周部にリング状の突起2eが設けられて、該突起2eが前記フィンガーグリップ4の円筒穴部4aに形成されたリング状溝4bに嵌合してしっかりとシリンダ2の後端の外周部に嵌着されている。前記フィンガーグリップ4は、シリンダ2に嵌着して設ける代わりに、シリンダ2と一体に形成して設けてもよい。   A ring-shaped protrusion 2d is provided on the outer peripheral portion of the front end of the cylinder 2, and the protrusion 2d is fitted into a ring-shaped groove 3i formed at the front end of the fitting hole 3d of the tube tip 3. As a result, the cylinder tip 3 is fitted in a gas-tight and liquid-tight manner to the front end portion of the cylinder 2, and similarly, a ring-shaped protrusion 2e is provided on the outer peripheral portion of the rear end of the cylinder 2, and the protrusion 2e is The finger grip 4 is fitted into a ring-shaped groove 4 b formed in the cylindrical hole 4 a of the finger grip 4 and is firmly fitted to the outer peripheral portion of the rear end of the cylinder 2. The finger grip 4 may be formed integrally with the cylinder 2 instead of being fitted to the cylinder 2.

次に、本発明の一実施の形態に係る容器兼用注射器1の作用について図6を参照しながら説明する。
前記構成の容器兼用注射器1においては、使用時には、先ず、容器兼用注射器1を図1に示す状態から、図6(a)に示すように、プランジャーロッド6をゆっくりと押して後部ストッパー5bを介して、後室2c内の薬液mをシリンダ2の前側へ少し送って前部ストッパー5aを前記シリンダ2のバイパス路2aの位置に押し込む。このとき、前部ストッパー5aによる薬液mの前側の封止が解かれるので、該薬液mは前記バイパス路2aの内側の通路2a1を通って前部ストッパー5aの前側の前室2bに流れ込むこととなる。バイパス路2aの位置に移動した前部ストッパー5aは、シリンダ2の内壁との間の摩擦抵抗によって、薬液mの流動圧力では前進することなく前記バイパス路2aの位置に止められている。
Next, the operation of the container / use syringe 1 according to one embodiment of the present invention will be described with reference to FIG.
In the case of the container / syringe 1 having the above-described configuration, when the container / syringe 1 is used, first, the plunger rod 6 is slowly pushed from the state shown in FIG. 1 through the rear stopper 5b as shown in FIG. 6 (a). Then, the chemical solution m in the rear chamber 2 c is sent to the front side of the cylinder 2 to push the front stopper 5 a into the bypass path 2 a of the cylinder 2. At this time, since the front seal of the chemical solution m by the front stopper 5a is released, the chemical solution m flows into the front chamber 2b on the front side of the front stopper 5a through the passage 2a1 inside the bypass passage 2a. Become. The front stopper 5a that has moved to the position of the bypass passage 2a is stopped at the position of the bypass passage 2a by the frictional resistance with the inner wall of the cylinder 2 without moving forward with the flow pressure of the chemical solution m.

さらに、図6(b)に示すように、前記プランジャーロッド6を押すことによって後部ストッパー5bの前側にある薬液mが順次前記バイパス路2aの通路2a1を通って前部ストッパー5aの前方へ流れて、バイパス路2aの前側の前室2b内へ移動する。ここで、前記後部ストッパー5bが前部ストッパー5aの後端面に当接して、薬液mが前記前室2b内に全て移動する。該前室2bに移動した薬液mを、使用者はシリンダ2の前室2bの外周側から十分に観察し、気泡も含めて薬液mにおける異常の有無を確認する。   Further, as shown in FIG. 6 (b), by pushing the plunger rod 6, the chemical solution m on the front side of the rear stopper 5b sequentially flows through the passage 2a1 of the bypass passage 2a to the front of the front stopper 5a. Then, it moves into the front chamber 2b on the front side of the bypass passage 2a. Here, the rear stopper 5b comes into contact with the rear end surface of the front stopper 5a, and the chemical solution m is completely moved into the front chamber 2b. The user sufficiently observes the chemical solution m moved to the front chamber 2b from the outer peripheral side of the front chamber 2b of the cylinder 2, and confirms whether there is an abnormality in the chemical solution m including bubbles.

なお、前記のようにシリンダ2のバイパス路2aの位置に前部ストッパー5bが押し込まれることにより、前側の密封を解除された薬液mがバイパス路2aを通って前室2b内に入り込む際、バイパス路2aの狭い通路2a1を通過した薬液mが前室2b内から一気にルアー先3aの通孔3f内に流れ込もうとするが、該通孔3fの入口側に前記薬液誘導部材9が装着されており、前記導入溝11cと流通溝10aからなる屈曲した薬液誘導路9aが、通孔3f内で薬液mの流れを効果的に緩和するので、注射針7の先端から薬液mが突出する水鉄砲現象が確実に防止される。   When the front stopper 5b is pushed into the position of the bypass passage 2a of the cylinder 2 as described above, the chemical solution m whose front seal is released enters the front chamber 2b through the bypass passage 2a. The chemical solution m that has passed through the narrow passage 2a1 of the passage 2a tries to flow into the through hole 3f of the lure tip 3a from the front chamber 2b at once. The chemical solution guide member 9 is mounted on the inlet side of the through hole 3f. Since the bent chemical solution guide path 9a composed of the introduction groove 11c and the flow groove 10a effectively relaxes the flow of the chemical solution m in the through hole 3f, the water gun which the chemical solution m protrudes from the tip of the injection needle 7 is provided. The phenomenon is reliably prevented.

この後、図6(c)に示すように、注射針7に被せてあるプロテクター8を前記筒先3から取り外し、薬液mの上部に残留する気泡があれば、前記プランジャーロッド6を適宜操作することにより、前記気泡をルアー先3aの通孔3fから注射針7を通して排出する。前記シリンダ2内から気泡を完全に除去してから、図6(d)に示すように、プランジャーロッド6を更に押して前部ストッパー5aを後部ストッパー5bを介して前室2bの前端(筒先3の嵌着穴3dの底部3e)まで前進させることにより注射を行う。   Thereafter, as shown in FIG. 6 (c), the protector 8 covered with the injection needle 7 is removed from the tube tip 3, and if there are bubbles remaining on the upper part of the drug solution m, the plunger rod 6 is appropriately operated. As a result, the bubbles are discharged through the injection needle 7 from the through hole 3f of the luer tip 3a. After completely removing bubbles from the cylinder 2, as shown in FIG. 6 (d), the plunger rod 6 is further pushed so that the front stopper 5a passes through the rear stopper 5b and the front end (cylinder tip 3). The injection is performed by advancing to the bottom 3e) of the fitting hole 3d.

前記のように、容器兼用注射器1においては、前記シリンダ2の後室2c内の薬液mが、シリンダ2のバイパス路2aの通路2a1を通してシリンダ2の前室2bに移動する時、前記バイパス路2aの狭い通路2a1を通って前室2bに勢い飛び込み、注射針7の先端から突出する水鉄砲現象を防止しながら、前記前室2b内において、注射の直前に、薬液mの気泡も含めて異常の有無を、透明なシリンダ2の外周側からしっかりと観察することができ、薬液mに異常のないことを確認してから安心して注射を行うことができる。   As described above, in the syringe 1 for both containers, when the drug solution m in the rear chamber 2c of the cylinder 2 moves to the front chamber 2b of the cylinder 2 through the passage 2a1 of the bypass passage 2a of the cylinder 2, the bypass passage 2a Immediately jumping into the front chamber 2b through the narrow passage 2a1 and preventing the water gun phenomenon protruding from the tip of the injection needle 7, while the front chamber 2b immediately before injection, including the bubbles of the drug solution m, Presence / absence can be firmly observed from the outer peripheral side of the transparent cylinder 2, and it is possible to perform the injection with peace of mind after confirming that there is no abnormality in the drug solution m.

以上説明したように、前記実施の形態に係る容器兼用注射器1は、透明な材料からなり、軸方向の中間部にシリンダ壁を外側に膨出してなるバイパス路2aが形成されたシリンダ2と、前記バイパス路2aの後側におけるシリンダ2の後室2c内にその軸方向に間隔をあけて嵌入され、前記後室2c内に充填された薬液mを相互間で液密に封止する前部ストッパー5aおよび後部ストッパー5bと、先端に注射針7を取り付けるルアー先3aが設けられ、基端部3bを前記シリンダ2の前端外周部に嵌着穴3dを介して嵌着された筒先3と、前記シリンダ2の後端外周部に嵌着して設けられたフィンガーグリップ4と、前記シリンダ2の後端部からシリンダ2内に挿入されて前記後部ストッパー5bに連結されたプランジャーロッド6とを備え、前記シリンダ2のバイパス路2aの長さLが前記前部ストッパー5aの軸長L1より長く設定されると共に、前記バイパス路2aの前側におけるシリンダ2の前室2bの長さL2が、前記シリンダ2の後室2c内で薬液で隔てられている前記前部ストッパー5aと後部ストッパー5bの相互間距離L3より長く設定され、また、前記筒先3のルアー先3aに形成されてシリンダ2の前室2b内に連通する通孔3fの内部に、シリンダ2側に位置して、シリンダ2から前記通孔3fに導入される薬液mを通孔3fの軸線に交差する方向から軸線に沿う方向へ屈折させて通過させる薬液誘導路9aを設けた薬液誘導部材9が装着された構成とされている。   As explained above, the container-use syringe 1 according to the above embodiment is made of a transparent material, and the cylinder 2 in which the bypass passage 2a formed by bulging the cylinder wall outward is formed in the intermediate portion in the axial direction; A front portion that is fitted into the rear chamber 2c of the cylinder 2 on the rear side of the bypass passage 2a with a space in the axial direction thereof, and seals the liquid medicine m filled in the rear chamber 2c in a liquid-tight manner. A stopper 5a, a rear stopper 5b, a luer tip 3a for attaching the injection needle 7 to the tip, and a tube tip 3 fitted with a base end 3b on the outer peripheral portion of the front end of the cylinder 2 through a fitting hole 3d; A finger grip 4 fitted to the outer peripheral portion of the rear end of the cylinder 2 and a plunger rod 6 inserted into the cylinder 2 from the rear end portion of the cylinder 2 and connected to the rear stopper 5b. Preparation The length L of the bypass path 2a of the cylinder 2 is set longer than the axial length L1 of the front stopper 5a, and the length L2 of the front chamber 2b of the cylinder 2 on the front side of the bypass path 2a 2 is set longer than the distance L3 between the front stopper 5a and the rear stopper 5b separated by the chemical solution in the rear chamber 2c, and is formed in the luer tip 3a of the cylinder tip 3 so as to be the front chamber of the cylinder 2. Refracted in the direction along the axis from the direction intersecting the axis of the through hole 3f of the chemical solution m introduced from the cylinder 2 into the through hole 3f in the through hole 3f communicating with 2b. The chemical liquid guiding member 9 provided with the chemical liquid guiding path 9a that is allowed to pass therethrough is mounted.

したがって、前記実施の形態に係る容器兼用注射器1によれば、シリンダ2のバイパス路2aの位置に前部ストッパー5aが押し込まれることにより、前側の密封を解除された薬液mが、バイパス路2aより後方のシリンダ2の後室2cから前記バイパス路2aを通ってバイパス路2aの前側のシリンダ2の前室2b内に全量入り込むので、該シリンダ2の前室2b内において、従来の容器兼用注射器の筒先では見えにくかった注射前の薬液の状態を、気泡も含めて透明なシリンダ2の前室2bの外側から良く観察することができ、安心して薬液を人体に注射することができる。   Therefore, according to the container / syringe 1 according to the above embodiment, the front side stopper 5a is pushed into the position of the bypass path 2a of the cylinder 2 so that the medicinal solution m whose front side is released from the bypass path 2a. Since the entire amount enters the front chamber 2b of the cylinder 2 on the front side of the bypass passage 2a from the rear chamber 2c of the rear cylinder 2 through the bypass passage 2a, the conventional container-combined syringe is placed in the front chamber 2b of the cylinder 2. The state of the drug solution before injection, which was difficult to see at the tip of the cylinder, can be well observed from the outside of the front chamber 2b of the transparent cylinder 2, including air bubbles, and the drug solution can be injected into the human body with peace of mind.

しかも、シリンダ2の前端部に嵌着された筒先3には、従来の容器兼用注射器の筒先のように、バイパス溝を有するバイパスチャンバーが設けられておらず、シリンダ2の中間部にバイパス路2aが設けてあり、薬液mが後室2cから通路2a1を通って前室2bへ移動するようになっている。そのため、プランジャーロッド6を押すことによって後部ストッパー5bの前側にある薬液mが前記バイパス路2aの通路2a1を通って勢い良くルアー先3aの通孔3f内に流れ込もうとするが、前記通孔3f内で薬液mの流れを前記薬液誘導部材9の薬液誘導路9aが効果的に緩和するので、注射針7の先端から薬液mが突出する水鉄砲現象を確実に防止することができる。   In addition, the tube tip 3 fitted to the front end of the cylinder 2 is not provided with a bypass chamber having a bypass groove unlike the tube tip of the conventional syringe serving as a container. The chemical solution m moves from the rear chamber 2c through the passage 2a1 to the front chamber 2b. Therefore, when the plunger rod 6 is pushed, the chemical solution m on the front side of the rear stopper 5b tends to flow through the passage 2a1 of the bypass passage 2a into the through hole 3f of the luer tip 3a. Since the chemical liquid guiding path 9a of the chemical liquid guiding member 9 effectively relaxes the flow of the chemical liquid m in the hole 3f, the water gun phenomenon in which the chemical liquid m protrudes from the tip of the injection needle 7 can be reliably prevented.

また、前記実施の形態に係る容器兼用注射器1によれば、前記筒先3のシリンダ2が嵌入される嵌着穴3dの底部3eには、前記通孔3fに連通しそれより大径の凹部3kが形成され、前記薬液誘導部材9が、前記通孔3fに嵌合される軸部10と、該軸部10のシリンダ2側の基端部に設けられて前記凹部3kに没入され、前記通孔3fより大径で前記凹部3kの外径より小径に形成され、前記凹部3kとの間に環状間隙eを形成するフランジ11と、該フランジ11の前記凹部3kの底面側に通孔3fの半径方向に向けて設けた導入溝11cおよび前記軸部10の外周に軸方向に沿って形成され、一端を前記導入溝11cに連絡され他端を前記軸部10の先端に開口させた流通溝10aで構成される薬液誘導路9aとを備えた構成とされているので、前記導入溝11cと流通溝10aとにより屈折した薬液誘導路9aを薬液誘導部材9に容易に形成することができると共に、ルアー先3aの通孔3f内の薬液の流れを的確に緩和することができる。   Further, according to the container combined syringe 1 according to the above embodiment, the bottom 3e of the fitting hole 3d into which the cylinder 2 of the tube tip 3 is fitted communicates with the through hole 3f and has a larger diameter recess 3k. The chemical solution guide member 9 is provided in the shaft portion 10 fitted in the through hole 3f and the base end portion of the shaft portion 10 on the cylinder 2 side, and is immersed in the recess portion 3k. A flange 11 having a diameter larger than that of the hole 3f and smaller than an outer diameter of the recess 3k and forming an annular gap e between the recess 3k, and a through hole 3f on the bottom surface side of the recess 3k of the flange 11 is formed. An introduction groove 11c provided in the radial direction and a flow groove formed on the outer periphery of the shaft portion 10 along the axial direction, having one end connected to the introduction groove 11c and the other end opened to the tip of the shaft portion 10. And a chemical solution guide path 9a composed of 10a. Therefore, the chemical liquid guiding path 9a refracted by the introduction groove 11c and the flow groove 10a can be easily formed in the chemical liquid guiding member 9, and the flow of the chemical liquid in the through hole 3f of the luer tip 3a can be moderately relaxed. can do.

また、前記実施の形態に係る容器兼用注射器1によれば、前記ルアー先3aの通孔3fが、前記嵌着穴3d側を大径としルアー先3aの先端側を小径としたテーパ孔に形成され、その嵌着穴3d側寄りの位置に周方向に沿って環状溝3jが設けられ、前記薬液誘導部材9の軸部10の外周に、前記通孔3fのテーパ孔に整合するテーパが設けられると共に、前記通孔3fの環状溝3jに嵌合する環状の突条10bが周方向に沿って設けられた構成とされているので、前記薬液誘導部材9をルアー先3aの通孔3fに軸部10を容易に挿入させて組み付けることができると共に、前記軸部10の環状の突条10bと前記通孔3fの環状溝3jとの嵌合により、前記薬液誘導部材9を前記通孔3f内にしっかりと保持させることができる。   Further, according to the container combined syringe 1 according to the above embodiment, the through hole 3f of the luer tip 3a is formed in a tapered hole having a large diameter on the fitting hole 3d side and a small diameter on the tip side of the luer tip 3a. An annular groove 3j is provided along the circumferential direction at a position closer to the fitting hole 3d side, and a taper that matches the tapered hole of the through hole 3f is provided on the outer periphery of the shaft portion 10 of the chemical solution guide member 9. In addition, since the annular protrusion 10b that fits in the annular groove 3j of the through hole 3f is provided along the circumferential direction, the chemical solution guide member 9 is placed in the through hole 3f of the luer tip 3a. The shaft portion 10 can be easily inserted and assembled, and the chemical liquid guide member 9 is inserted into the through hole 3f by fitting the annular protrusion 10b of the shaft portion 10 with the annular groove 3j of the through hole 3f. It can be securely held inside.

なお、前記実施の形態に係る容器兼用注射器1においては、前記薬液誘導部材9にその周方向に間隔をあけて4個の薬液誘導路9aを設けたが、該薬液誘導路9aの個数は、これに限らず1個または4個以外の複数個設けてもよい。また、前記薬液誘導路9aを薬液誘導部材9の軸部10の外周と内側フランジ部11bに設けた流通溝10aと導入溝11cとにより、薬液誘導部材9(通孔3f)の軸線に垂直に交差させて構成したが、これに限らず、前記軸部10中にその軸線方向に向けてあけた流通孔と、この流通孔に直交して連絡するように前記フランジ11に設けた導入孔とで構成してもよい。さらに、前記導入溝11cと導入孔は、それぞれ薬液誘導部材9(通孔3f)の軸線に垂直に交差させる必要はなく、傾斜して交差させるようにしてもよい。また、前記筒先3の通孔3fと前記薬液誘導部材9の軸部10をそれぞれテーパ孔、テーパ軸に形成したので、組立時に通孔3fに軸部10を容易に挿入して嵌合させることができて好ましいが、前記通孔3fと軸部10をそれぞれ平行孔、平行軸として形成してもよい。   In the container combined syringe 1 according to the above embodiment, the drug solution guide member 9 is provided with four drug solution guide paths 9a at intervals in the circumferential direction. The number of the drug solution guide paths 9a is as follows. The present invention is not limited to this, and a plurality other than one or four may be provided. Further, the chemical liquid guiding path 9a is perpendicular to the axis of the chemical liquid guiding member 9 (through hole 3f) by the flow groove 10a and the introducing groove 11c provided in the outer periphery of the shaft portion 10 of the chemical liquid guiding member 9 and the inner flange portion 11b. Although it was configured to intersect, the present invention is not limited thereto, and a through hole formed in the shaft portion 10 in the axial direction, and an introduction hole provided in the flange 11 so as to communicate perpendicularly to the through hole. You may comprise. Furthermore, the introduction groove 11c and the introduction hole do not have to intersect each other perpendicularly to the axis of the chemical liquid guiding member 9 (through hole 3f), and may be inclined and intersect. Further, since the through hole 3f of the tube tip 3 and the shaft portion 10 of the chemical liquid guiding member 9 are formed as a tapered hole and a tapered shaft, respectively, the shaft portion 10 can be easily inserted and fitted into the through hole 3f during assembly. However, the through hole 3f and the shaft portion 10 may be formed as a parallel hole and a parallel axis, respectively.

なお、前記実施の形態に係る容器兼用注射器1においては、本発明を一室式容器兼用注射器に適用した例を示したが、本発明はこれに限らず、二室式容器兼用注射器にも適用することができる。この場合は、前記バイパス路2aより前側のシリンダ2内の容積がシリンダ内の二室の薬剤の容積の合計容積以上に相当するものとする必要があるので、容器兼用注射器の全長が多少長くなる。
また、この場合には、図7〜図10に示すように、前記薬液誘導部材9は、前記フランジ11の外側フランジ部11aにおける外端部(シリンダ2側の端部)に、前記凹部3kの内径より大径の円形のフランジ板11dが一体に設けられると共に、該フランジ板11dには、前記シリンダ2内を前記環状間隙eに連通させる複数の小孔11eをフランジ板11dの周方向に間隔をあけて配設されている。そして、前記フランジ板11dは、その内側(凹部3k側)面に環状に形成された網目状のフィルター12が前記小孔11eを覆うようにして接着されて装着され、その外周部が前記嵌着穴3dの底部3eに前記フィルター12を介して密着されるように設けられている。
なお、前記フランジ板11dの内面側は、前記装着穴3dの底部3eの傾斜面に整合する傾斜面に形成されている。
In addition, in the container combined use syringe 1 which concerns on the said embodiment, although the example which applied this invention to the single chamber type container combined use syringe was shown, this invention is not limited to this but is applied also to the two chamber type container combined use syringe. can do. In this case, since the volume in the cylinder 2 on the front side of the bypass passage 2a needs to be equal to or more than the total volume of the medicines in the two chambers in the cylinder, the total length of the syringe serving as a container is somewhat longer. .
Further, in this case, as shown in FIGS. 7 to 10, the chemical solution guide member 9 is formed on the outer end portion (end portion on the cylinder 2 side) of the outer flange portion 11 a of the flange 11. A circular flange plate 11d having a diameter larger than the inner diameter is integrally provided, and a plurality of small holes 11e communicating the inside of the cylinder 2 with the annular gap e are spaced in the flange plate 11d in the circumferential direction of the flange plate 11d. It is arranged with a gap. Then, the flange plate 11d is attached to the inner surface (recess 3k side) with a mesh-like filter 12 formed in an annular shape so as to cover the small hole 11e, and the outer periphery thereof is attached to the flange plate 11d. It is provided to be in close contact with the bottom 3e of the hole 3d through the filter 12.
In addition, the inner surface side of the flange plate 11d is formed on an inclined surface that matches the inclined surface of the bottom portion 3e of the mounting hole 3d.

この構成によれば、二室式容器兼用注射器において、凍結乾燥製剤を溶解液に液状に溶解させて注射する場合に、万一、シリンダ2内の薬液m中に乾燥製剤の不溶物が発生しても、該不溶物は、薬液mがシリンダ2内から前記ルアー先3aの通孔3fに入る際に、前記フィルター12によって濾過されることによって前記環状間隙eへの侵入を阻止されるるので、前記不溶物が前記ルアー先3aの通孔3fを通って注射針7から人体に注入されるのを確実に防止することができる。
また、前記フィルター12を前記フランジ板11dの内側面に装着したが、フランジ板11dの外面側に装着してもよく、このようにフランジ板11dにフィルター12を装着すると、シリンダ2内からルアー先3aの通孔3f内に薬液mが入り込む入口部に、フィルター12をしっかりと安定した状態で容易に設置することができる。しかし、これに限らず、前記フィルター12は、前記外側フランジ11aの外端面と装着穴3dの底部3eとに直接に接着等により設けて前記環状間隙eを覆うようにしてもよい。
According to this configuration, when a lyophilized preparation is dissolved in a solution and injected in a two-chamber type syringe, an insoluble matter of the dry preparation is generated in the drug solution m in the cylinder 2. However, the insoluble matter is prevented from entering the annular gap e by being filtered by the filter 12 when the chemical solution m enters the through hole 3f of the luer tip 3a from within the cylinder 2. It is possible to reliably prevent the insoluble matter from being injected into the human body from the injection needle 7 through the through hole 3f of the luer tip 3a.
Further, the filter 12 is mounted on the inner surface of the flange plate 11d. However, the filter 12 may be mounted on the outer surface side of the flange plate 11d. The filter 12 can be easily installed in a stable and stable state at the entrance where the chemical solution m enters the through hole 3f of 3a. However, the present invention is not limited thereto, and the filter 12 may be provided directly on the outer end surface of the outer flange 11a and the bottom 3e of the mounting hole 3d by bonding or the like so as to cover the annular gap e.

本発明の一実施の形態に係る容器兼用注射器を示す縦断面図である。It is a longitudinal cross-sectional view which shows the container combined use syringe which concerns on one embodiment of this invention. 同じく容器兼用注射器の筒先の縦断面図である。It is the longitudinal cross-sectional view of the cylinder tip of a syringe used also as a container. 同じく筒先内に設ける薬液誘導部材を示す斜視図である。It is a perspective view which similarly shows the chemical | medical solution guide member provided in a cylinder tip. 同じく薬液誘導部材の側面図である。It is a side view of a chemical | medical solution guide member similarly. 図4のイ矢視図である。FIG. 5 is a view taken in the direction of arrow A in FIG. 4. 本発明の一実施の形態に係る容器兼用注射器の作用を示す縦断面図である。It is a longitudinal cross-sectional view which shows the effect | action of the container combined use syringe which concerns on one embodiment of this invention. 本発明の他の実施の形態に係る容器兼用注射器における筒先を示す縦断面図である。It is a longitudinal cross-sectional view which shows the cylinder tip in the syringe with a container which concerns on other embodiment of this invention. 同じく筒先内に設ける薬液誘導部材を示す斜視図である。It is a perspective view which similarly shows the chemical | medical solution guide member provided in a cylinder tip. 同じく薬液誘導部材の側面図である。It is a side view of a chemical | medical solution guide member similarly. 図9のロ矢視図である。FIG. 10 is a view in the direction of arrow B in FIG. 9.

符号の説明Explanation of symbols

1 容器兼用注射器
2 シリンダ
2a バイパス路
2b 前室
2c 後室
3 筒先
3a ルアー先
3b 基端部
3d 嵌着穴
3f 通孔
3j 環状溝
4 フィンガーグリップ
5a,5b 前、後部ストッパー
6 プランジャーロッド
7 注射針
8 プロテクター
9 薬液誘導部材
9a 薬液誘導路
10 軸部
10a 流通溝
10b 突条
11 フランジ
11c 導入溝
11d フランジ板
12 フィルター
L バイパス路の長さ
L1 前部ストッパーの長さ(軸長)
L2 前室の長さ
L3 前、後部ストッパーの相互間距離
m 薬液
DESCRIPTION OF SYMBOLS 1 Syringe and syringe 2 Cylinder 2a Bypass path 2b Front chamber 2c Rear chamber 3 Tube tip 3a Luer tip 3b Base end portion 3d Insertion hole 3f Through-hole 3j Annular groove 4 Finger grip 5a, 5b Front, rear stopper 6 Plunger rod 7 Injection Needle 8 Protector 9 Chemical liquid guiding member 9a Chemical liquid guiding path 10 Shaft portion 10a Flow groove 10b Projection 11 Flange 11c Introduction groove 11d Flange plate 12 Filter L Length of bypass path L1 Length of front stopper (shaft length)
L2 Length of front chamber L3 Distance between front and rear stoppers m Chemical solution

Claims (5)

透明な材料からなり、軸方向の中間部にシリンダ壁を外側に膨出してなるバイパス路が形成されたシリンダと、前記バイパス路の後側におけるシリンダの後室内にその軸方向に間隔をあけて嵌入され、後室内に充填された薬液を相互間で液密に封止する前部ストッパーおよび後部ストッパーと、先端に注射針を取り付けるルアー先が設けられ、基端部を前記シリンダの前端外周部に嵌着された筒先と、前記シリンダの後端外周部に設けられたフィンガーグリップと、前記シリンダの後端部からシリンダ内に挿入されて前記後部ストッパーに連結されたプランジャーロッドとを備えた容器兼用注射器であって、
前記シリンダのバイパス路の長さが前記前部ストッパーの軸長より長く設定されると共に、前記バイパス路の前側におけるシリンダの前室の長さが前記シリンダの後室内で薬液で隔てられている前記前部ストッパーと後部ストッパーの相互間距離より長く設定され、また、前記筒先のルアー先に形成されてシリンダに連通する通孔には、シリンダ側に位置して、シリンダ内から前記通孔に導入される薬液を通孔の軸線に交差する方向から軸線に沿う方向へ屈折させて通過させる薬液誘導路を設けた薬液誘導部材が装着されていることを特徴とする容器兼用注射器。
A cylinder made of a transparent material and having a bypass passage formed by bulging the cylinder wall outward in an axially intermediate portion, and an axial space in the rear chamber of the cylinder on the rear side of the bypass passage A front stopper and a rear stopper for sealing the liquid medicine inserted and filled in the rear chamber in a liquid-tight manner, and a luer tip for attaching an injection needle to the tip are provided, and a base end is an outer periphery of the front end of the cylinder And a finger grip provided on the outer periphery of the rear end of the cylinder, and a plunger rod inserted into the cylinder from the rear end of the cylinder and connected to the rear stopper. A container combined syringe,
The length of the bypass path of the cylinder is set longer than the axial length of the front stopper, and the length of the front chamber of the cylinder on the front side of the bypass path is separated by a chemical in the rear chamber of the cylinder The through hole that is set longer than the distance between the front stopper and the rear stopper and that is formed in the luer tip of the cylinder tip and communicates with the cylinder is located on the cylinder side and introduced into the through hole from within the cylinder. A container-use syringe equipped with a medicinal solution guiding member provided with a medicinal solution guiding path for allowing the medicinal solution to be refracted from the direction intersecting the axis of the hole to the direction along the axis and passing therethrough.
前記筒先のシリンダが嵌入される嵌着穴の底部には、前記通孔に連通しそれより大径の凹部が形成され、前記薬液誘導部材は、前記通孔に嵌合される軸部と、該軸部のシリンダ側の基端部に設けられて前記凹部に没入され、前記通孔より大径で前記凹部の外径より小径に形成され、前記凹部との間に環状間隙を形成するフランジと、該フランジの前記凹部の底面側に通孔の半径方向に向けて設けた導入溝および前記軸部の外周に軸方向に沿って形成され、一端を前記導入溝に連絡され他端を前記軸部の先端に開口させた流通溝で構成される薬液誘導路とを備えていることを特徴とする請求項1に記載の容器兼用注射器。   At the bottom of the fitting hole into which the cylinder at the cylinder tip is fitted, a recess having a larger diameter communicating with the through-hole is formed, and the chemical solution guide member has a shaft portion fitted into the through-hole, A flange that is provided at a base end portion of the shaft portion on the cylinder side, is immersed in the recess, has a diameter larger than the through hole and smaller than an outer diameter of the recess, and forms an annular gap with the recess And an introduction groove provided on the bottom surface side of the concave portion of the flange toward the radial direction of the through hole and an outer periphery of the shaft portion along the axial direction, one end being connected to the introduction groove and the other end being the 2. The container-use syringe according to claim 1, further comprising a drug solution guide path configured by a flow groove opened at a tip of the shaft portion. 前記ルアー先の通孔は、前記嵌着穴側を大径としルアー先の先端側を小径としたテーパ孔に形成され、その嵌着穴側寄りの位置に周方向に沿って環状溝が設けられ、前記薬液誘導部材の軸部の外周には、前記通孔のテーパ孔に整合するテーパが設けられると共に、前記通孔の環状溝に嵌合する環状の突条が周方向に沿って設けられていることを特徴とする請求項2に記載の容器兼用注射器。   The luer tip through hole is formed in a tapered hole having a large diameter on the fitting hole side and a small diameter on the tip side of the luer tip, and an annular groove is provided along the circumferential direction at a position near the fitting hole side. A taper that matches the tapered hole of the through hole is provided on the outer periphery of the shaft portion of the chemical liquid guiding member, and an annular protrusion that fits in the annular groove of the through hole is provided along the circumferential direction. The container-use syringe according to claim 2, wherein the syringe is used as a container. 前記凹部とフランジとの間の環状間隙におけるシリンダ側の端部には、薬液中の不溶物の環状間隙への侵入を阻止するフィルターが設けられていることを特徴とする請求項2または3に記載の容器兼用注射器。   4. The filter according to claim 2 or 3, wherein a filter for preventing an insoluble matter in the chemical solution from entering the annular gap is provided at an end of the annular gap between the recess and the flange. The container combined use syringe described. 前記フランジにおけるシリンダ側の端部には、前記シリンダ内を前記環状間隙に連通させる複数の小孔を周方向に間隔をあけて配設したフランジ板が、その外周部を前記嵌着穴の底部に密着されるように設けられ、前記フィルターが前記小孔を覆うようにしてフランジ板に装着されていることを特徴とする請求項4に記載の容器兼用注射器。   At the end of the flange on the cylinder side, there is a flange plate in which a plurality of small holes communicating with the annular gap in the cylinder are arranged at intervals in the circumferential direction, and the outer peripheral portion thereof is the bottom of the fitting hole. The container-use syringe according to claim 4, wherein the syringe is provided so as to be in close contact with the flange plate, and the filter is attached to the flange plate so as to cover the small hole.
JP2006289730A 2006-10-25 2006-10-25 Container-cum-syringe Pending JP2008104623A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006289730A JP2008104623A (en) 2006-10-25 2006-10-25 Container-cum-syringe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006289730A JP2008104623A (en) 2006-10-25 2006-10-25 Container-cum-syringe

Publications (1)

Publication Number Publication Date
JP2008104623A true JP2008104623A (en) 2008-05-08

Family

ID=39438478

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006289730A Pending JP2008104623A (en) 2006-10-25 2006-10-25 Container-cum-syringe

Country Status (1)

Country Link
JP (1) JP2008104623A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4757951B1 (en) * 2010-10-19 2011-08-24 株式会社アルテ Two-chamber syringe

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4757951B1 (en) * 2010-10-19 2011-08-24 株式会社アルテ Two-chamber syringe
US8517983B2 (en) 2010-10-19 2013-08-27 Arte Corporation Dual chamber combined container-syringe

Similar Documents

Publication Publication Date Title
JP5491951B2 (en) Automatic syringe and method of assembling the automatic syringe
US7544189B2 (en) Needle and hub assembly for automatic injector
JP2726906B2 (en) Injection device
JP4682850B2 (en) Prefilled syringe
US4496344A (en) Multiple-compartment syringe
JPS6258745B2 (en)
KR101618028B1 (en) Assembled filter for syringe, syringe and assembled ringer comprising thereof
JP2007185319A5 (en)
EP3492127B1 (en) Liquid medicine injection apparatus capable of injecting additional fluid after completion of liquid medicine injection
JP2009532151A (en) Needleless injection system for delivering drugs by high pressure
JP2017510326A (en) Discharge device
KR101466764B1 (en) Safety syringe with filter element
KR20200068525A (en) Gasket for syringe with residual discharge
JP2008099728A (en) Syringe serving also as container
JP2008104623A (en) Container-cum-syringe
KR101479258B1 (en) Disposable syringe
JP2008104776A (en) Container-cum-syringe
KR101559286B1 (en) Cartridges-Mounted Syringe
KR101536584B1 (en) Needle and injector thereof
EP2191860A1 (en) Combined container-syringe
KR20180054114A (en) Smart syringe with re-use prevention feature
US20170100544A1 (en) Fluid transfer mechanism for needle-free injection device
KR101742803B1 (en) Safety filter syringe
US10532158B2 (en) Fluid transfer mechanism for an injection device
JP2021137451A (en) Double chamber-type pre-filled syringe

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090616

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091020